Mizuho Securities Remains Neutral on HCP, Inc. (HCP) - Cuts PT to $26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
HCP Announces Results for the Fourth Quarter and Year Ended December 31, 2015
February 9, 2016 8:02 AM ESTIRVINE, Calif., Feb. 9, 2016 /PRNewswire/ --
FOURTH QUARTER 2015 AND RECENT HIGHLIGHTS
--   FFO as adjusted and FAD per share increased year-over-year by 1% to $0.80 and 2% to $0.67, respectively; FFO per share and EPS were ($0.99) and ($1.29), respectively (see "HCR ManorCare Update" on page 3)  --   Raised $1.1 billion from capital recycling and financing activities, including $600 million of 4.0% senior unsecured notes that paid down 36% of 2016 debt maturities --   Completed $208 million of investment transactions --   Leased 911,000 sq. ft. in our life science and medical office ("MOB") portfolios, bringing occupancy to 98.2% and 91.9%, respectively --   Pre-leased half of Phase I of The Cove life science development, and... More
